In this episode, Jay Jackson, CEO of Abacus Global Management, discusses the evolution of life insurance as an investment vehicle, the importance of treating life insurance as personal property, and the role of data and technology in predicting mortality. He emphasizes the significance of AI in transforming the insurance industry and shares insights on balancing innovation with revenue generation. The discussion highlights the value of lifespan and the purpose behind their business in providing financial solutions.

Abacus Global Management Website: https://abacusgm.com/

Nano Cap Podcast Website: https://www.nanocappod.com/

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Vin Singh, CEO of Bullfrog AI, discusses his journey from founding Maxite to leading Bullfrog AI, a company focused on using AI for drug discovery. He shares insights on the challenges in drug development, the importance of proprietary data, and the company's partnerships that have led to significant discoveries in neuropsychiatric disorders. Vin emphasizes the mission of saving lives through technology and outlines the go-to-market strategy for Bullfrog AI.

BullfrogAI website: https://bullfrogai.com/

Nano Cap Pod Website: https://www.nanocappod.com/

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Greg Duncan, CEO of Dogwood Therapeutics, discusses his extensive career in the biotech industry, the formation of Dogwood Therapeutics, and the innovative non-opioid pain management solution, Halneuron. He elaborates on the clinical trials for Halneuron, its potential applications, and the company's focus on addressing pain and neuropathy associated with chemotherapy. Additionally, Duncan shares insights into other therapeutic avenues being explored by Dogwood, including treatments for fibromyalgia and long COVID, and emphasizes the importance of improving patient quality of life.

Dogwood Therapeutics Website: https://www.dwtx.com/

Nano Cap Podcast Website: https://www.nanocappod.com/

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, David Moss, CEO of INmune Bio, discusses his journey in the biotech industry, the founding of INmune Bio, and the company's focus on modulating the innate immune system to develop therapies for diseases like Alzheimer's and rare pediatric conditions. He emphasizes the importance of scientific integrity in research and the challenges faced in the Alzheimer's space, while also sharing his personal motivations for driving the company's mission forward.

Takeaways

• David Moss has a long-standing passion for biotech, influenced by family connections.
• INmune Bio focuses on the innate immune system, which is often overlooked in drug development.
• The company was founded to create affordable therapies for complex diseases.
• Their product platforms include Chordstrom for rare diseases and Expro for Alzheimer's.
• Alzheimer's disease represents a significant unmet medical need with millions affected.
• Recruiting patients for clinical trials is a structured process, not a marketing campaign.
• David's personal connection to Alzheimer's motivates his work at INmune Bio.
• The company aims to disrupt chronic inflammation to improve cognitive function.
• Expro is designed to be a lifelong treatment for Alzheimer's patients.
• INmune Bio is open to discussions with investors and interested parties.

INmune Bio website: https://www.inmunebio.com/

Nano Cap Podcast Website: https://www.nanocappod.com/

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Andrew Brodkey, CEO of Idaho Copper, discusses his unique background in mining and law, the evolution of the mining industry, and the specifics of the CuMo project. He highlights the importance of responsible mining practices, the dynamics of copper pricing, and the innovative ore sorting technology that could enhance the project's economic viability. Brodkey also addresses the challenges faced in the mining sector, including regulatory hurdles and supply chain dynamics, while expressing optimism about the future of Idaho Copper and the demand for critical minerals.

Idaho Copper Website - https://www.idaho-copper.com/

Nano Cap Podcast Website: https://www.nanocappod.com/

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, Dr. Joseph Sinkule, CEO of Klotho Neurosciences, discusses his extensive background in medical research and entrepreneurship, focusing on the development of innovative therapies for age-related cognitive and neurodegenerative disorders. He explains the significance of the Klotho protein, its potential in gene therapy, and the company's strategic approach to addressing diseases like Alzheimer's and ALS. The discussion also touches on the importance of diagnostics and the future vision for extending healthy lifespans.

Klotho Neurosciences website: https://klothoneuro.com/

Episode Notes

• Dr. Sinkule has transitioned from clinical practice to entrepreneurship over 46 years.
• Klotho Neurosciences focuses on developing therapies for neurodegenerative diseases.
• The Klotho protein is linked to anti-aging and cognitive enhancement.
• Gene therapy using Klotho has potential applications in ALS and Alzheimer's.
• Diagnostics play a crucial role in identifying candidates for Clotho therapies.
• The company aims to balance research with practical business strategies.
• Dr. Sinkule emphasizes the importance of early intervention in neurodegenerative diseases.

Nano Cap Podcast Website: https://www.nanocappod.com/

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode, David Crean, Chief Business Officer of Medici Nova, shares his journey from academia to the biopharmaceutical industry. He discusses his early career, pivotal moments, and the unique business model of MediciNova, which focuses on addressing unmet medical needs in challenging diseases like ALS. Crean emphasizes the importance of capital efficiency in drug development and outlines the exciting projects currently underway at MediciNova, highlighting the potential impact on patients.

MediciNova Website - https://medicinova.com/

Nano Cap Podcast - https://www.nanocappod.com/

Takeaways

• David Crean transitioned from academia to the biopharmaceutical industry.

• He values education and holds both a PhD and an MBA.

• MediciNova focuses on unmet medical needs, particularly in ALS.

• The company operates with a unique, capital-efficient business model.

• Crean emphasizes the importance of strategic corporate finance and development.

• He has a strong interest in drug commercialization and development.

• MediciNova has a pipeline of promising compounds with existing data.

• The company is close to finalizing patient enrollment for key trials.

• Crean is excited about the potential impact of their drugs on patients.

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

This Episode, Joseph Pandolfino discusses his journey in the alternative tobacco industry, starting from his discovery of herbal cigarettes to the development of low nicotine products blended with hemp. He shares insights on the challenges and innovations in creating products that cater to smokers looking to reduce their nicotine intake. The discussion also covers the regulatory landscape, patent strategies, and the future of tobacco products in both domestic and international markets.

Cabbacis Website https://www.cabbacis.com/

Nano Cap Podcast https://www.nanocappod.com/

Takeaways

• Joseph discovered herbal cigarettes in a health food store.
• He genetically engineered tobacco to reduce nicotine content.
• The addition of hemp improved the taste of low nicotine cigarettes.
• Joseph holds 35 patents related to tobacco and hemp products.
• The US has stringent regulations for new tobacco products.
• Cabbacis plans to file a pre-market tobacco application soon.
• Cigarettes remain the most consumed tobacco product globally.
• Keeping expenses low is crucial for business sustainability.
• The management team is compensated with equity, not salary.
• Cabbacis aims to target English-speaking countries for expansion.
  

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this conversation, Ben Hwang, CEO of Profusa, shares his unique journey from working with the Dodgers to leading a company focused on innovative biosensors. He discusses the vision behind Profusa, the challenges of transforming healthcare through technology, and the importance of real-time data in managing chronic diseases. Hwang emphasizes the need for accessible and clinically validated health solutions and outlines the future aspirations of the company in scaling their technology to benefit a wider audience.

Profusa Website - https://profusa.com/

Nano Cap Podcast Website - https://www.nanocappod.com/

Takeaways

• Ben's early experiences with the Dodgers shaped his career.

• He transitioned from sports to academia, earning a PhD.

• Profusa aims to revolutionize healthcare with real-time data.

• The importance of clinical validation in health tech.

• User experience is crucial for technology adoption.

• The vision for Profusa has remained consistent over the years.

• Data must be meaningful for healthcare decisions.

• The company focuses on chronic disease management.

• Future products will expand beyond glucose monitoring.

• Accessibility of technology is a key mission for Profusa.

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.

In this episode I interview JW Roth, CEO and founder of Venu Holding Corporation, shares his journey from being a police officer to becoming an entrepreneur in the entertainment and hospitality industry. He discusses the innovative business model of fractional ownership in music venues, the importance of creating a premium experience for concert-goers, and the expansion of his company into hospitality services. Roth emphasizes his passion for live music and his commitment to building venues that cater to fans' needs, ultimately aiming to disrupt the traditional concert experience.

Venu Website https://venu.live/

Nano Cap Podcast Website https://www.nanocappod.com/

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.